BBS-Bioactive Bone Substitutes Plc, Company announcement, management transactions, 7 August 2023 at 16.00 (EEST)
BBS-Bioactive Bone Substitutes Oyj – Managers’ Transactions – Ahti Paananen
This Company announcement contains information on the following management transactions:
____________________________________________
Person subject to the notification requirement
Name: Paananen Ahti
Position: Member of the Board/Deputy member
Issuer: BBS Bioactive Bone Substitutes Oyj
LEI: 743700BYSBP0PCR6N767
Notification type: INITIAL NOTIFICATION
Reference number: 743700BYSBP0PCR6N767_20230803192300_8
____________________________________________
Transaction date: 2022-12-05
Venue not applicable
Instrument type: SHARE
ISIN: FI4000260583
Nature of the transaction: SUBSCRIPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 20,836 Unit price: 0.92 EUR
Aggregated transactions
(1): Volume: 20,836 Volume weighted average price: 0.92 EUR
Contact information:
Ilkka Kangasniemi, CEO
040 708 0307
ilkka.kangasniemi@bbs-artebone.fi
The digital therapeutics market is experiencing rapid growth, driven by rising demand for personalized, evidence-based…
CARY, N.C., Aug. 13, 2025 /PRNewswire/ -- InstantGMP™, a leading provider of software solutions for…
Marpai Slashes Losses by Two-Thirds in Q2 2025, Paving the Way to Profitability.Operating Expenses Cut…
CMI.ai by Blue Purpose — the first AI solution within the VIBE platform built to…
Presented by Elton John, David Furnish, and Charlotte Tilbury One trendsetter will attend Versace's 2026…
NEW YORK, Aug. 13, 2025 /PRNewswire/ -- HopeAI , a Mayo Clinic Platform Accelerate company,…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="1px" width="1px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
